US7641780B2
(en)
*
|
2001-05-01 |
2010-01-05 |
Calibrant Biosystems, Inc. |
Two-dimensional microfluidics for protein separations and gene analysis
|
EP1601450B1
(en)
*
|
2003-03-10 |
2013-06-05 |
Expression Pathology, Inc. |
Liquid tissue preparation from histopatologically processed biological samples, tissues and cells
|
US7381440B2
(en)
*
|
2003-06-06 |
2008-06-03 |
The United States Of America As Represented By The Secretary Of The Navy |
Biological laser printing for tissue microdissection via indirect photon-biomaterial interactions
|
US8012693B2
(en)
|
2003-12-16 |
2011-09-06 |
3M Innovative Properties Company |
Analysis of chemically crosslinked cellular samples
|
DE102005023011A1
(de)
*
|
2005-05-19 |
2006-11-23 |
Qiagen Gmbh |
Quantitative Proteinbestimmung von Formalin fixiertem Gewebe
|
US8609345B2
(en)
*
|
2005-05-25 |
2013-12-17 |
Expression Pathology Incorporated |
Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations
|
JP5166250B2
(ja)
*
|
2005-05-25 |
2013-03-21 |
エクスプレッション、パソロジー、インコーポレイテッド |
組織病理学的に処理した生物学的試料からのプロテオームの適用範囲を増加させるための、液体組織標品を用いたマルチプレックス方法
|
JP2008541761A
(ja)
*
|
2005-05-31 |
2008-11-27 |
インヴィトロジェン コーポレーション |
パラフィン含有試料からの核酸の分離及び精製
|
DE102005027172A1
(de)
|
2005-06-13 |
2006-12-14 |
Merck Patent Gmbh |
Verwendung von Ionischen Flüssigkeiten zur Proteinextraktion
|
EP1891433B1
(en)
*
|
2005-06-16 |
2012-03-07 |
3M Innovative Properties Company |
Method of classifying chemically crosslinked cellular samples using mass spectra
|
DE102005060738A1
(de)
*
|
2005-12-16 |
2007-06-21 |
Qiagen Gmbh |
Verfahren zur Extraktion von Biomolekülen aus fixierten Geweben
|
WO2007112350A2
(en)
*
|
2006-03-24 |
2007-10-04 |
Expression Pathology |
Method of assessing the metastatic status of a primary tumor
|
JP2008043332A
(ja)
*
|
2006-08-17 |
2008-02-28 |
Panomics Inc |
組織スライドからの核酸定量
|
JPWO2008038813A1
(ja)
*
|
2006-09-28 |
2010-01-28 |
株式会社島津製作所 |
パラフィン包埋標本の脱パラフィン法及びパラフィン包埋標本の解析法
|
US20080156080A1
(en)
*
|
2007-01-02 |
2008-07-03 |
Calibrant Biosystems, Inc. |
Methods and systems for multidimensional concentration and separation of biomolecules using capillary isotachophoresis
|
US20080160629A1
(en)
*
|
2007-01-02 |
2008-07-03 |
Calibrant Biosystems, Inc. |
Methods and systems for off-line multidimensional concentration and separation of biomolecules
|
US9284409B2
(en)
|
2007-07-19 |
2016-03-15 |
Boston Scientific Scimed, Inc. |
Endoprosthesis having a non-fouling surface
|
JP2010535541A
(ja)
|
2007-08-03 |
2010-11-25 |
ボストン サイエンティフィック リミテッド |
広い表面積を有する医療器具用のコーティング
|
ES2423504T3
(es)
|
2008-04-22 |
2013-09-20 |
Boston Scientific Scimed, Inc. |
Dispositivos médicos que tienen un recubrimiento de material inorgánico
|
WO2009132176A2
(en)
|
2008-04-24 |
2009-10-29 |
Boston Scientific Scimed, Inc. |
Medical devices having inorganic particle layers
|
EP2193831A1
(de)
*
|
2008-12-05 |
2010-06-09 |
Qiagen GmbH |
Parallel-Extraktion von unterschiedlichen Biomolekülen aus Formalin-fixiertem Gewebe
|
DE202009018981U1
(de)
|
2009-07-01 |
2015-03-11 |
Axagarius Gmbh & Co. Kg |
Verwendung eines Kits für die Isolierung von Biomolekülen aus biologischen Proben sowie Kit dafür
|
EP3260859B1
(en)
|
2009-12-22 |
2020-02-05 |
Expression Pathology, Inc. |
Inuslin receptor substrate 1 (irs1) protein srm/mrm assay
|
AU2010341489A1
(en)
|
2009-12-22 |
2012-07-19 |
Expression Pathology, Inc. |
Secreted Protein Acidic and Rich in Cysteine (SPARC) protein SRM/MRM assay
|
WO2011087868A1
(en)
*
|
2009-12-22 |
2011-07-21 |
Expression Pathology, Inc. |
Insulin-like growth factor 1 receptor (igf-1r) protein srm/mrm assay
|
WO2011087865A1
(en)
*
|
2009-12-22 |
2011-07-21 |
Expression Pathology, Inc. |
Epidermal growth factor receptor (egfr) protein srm/mrm assay
|
US10787701B2
(en)
|
2010-04-05 |
2020-09-29 |
Prognosys Biosciences, Inc. |
Spatially encoded biological assays
|
US20190300945A1
(en)
|
2010-04-05 |
2019-10-03 |
Prognosys Biosciences, Inc. |
Spatially Encoded Biological Assays
|
WO2011150245A2
(en)
*
|
2010-05-26 |
2011-12-01 |
Expression Pathology, Inc. |
Urokinase-type plasminogen activator protein/plasminogen activator inhibitor type-1 protein-selected reaction monitoring assay
|
EP2601519B1
(en)
*
|
2010-07-30 |
2017-12-06 |
Expression Pathology, Inc. |
C-src selected reaction monitoring assay
|
WO2012048335A2
(en)
|
2010-10-08 |
2012-04-12 |
The University Of North Carolina At Chapel Hill |
Formulation of acoustically activatable particles having low vaporization energy and methods for using same
|
CA2823195C
(en)
|
2010-12-27 |
2019-12-03 |
Expression Pathology, Inc. |
Cmet protein srm/mrm assay
|
WO2012097276A2
(en)
|
2011-01-13 |
2012-07-19 |
Expression Pathology, Inc. |
Bcl-2-like protein 11 srm/mrm assay
|
CN102146112B
(zh)
*
|
2011-01-25 |
2013-07-10 |
天根生化科技(北京)有限公司 |
从福尔马林固定石蜡包埋组织中提取脱氧核糖核酸的方法
|
US9372196B2
(en)
|
2011-03-08 |
2016-06-21 |
Bioproximity, Llc |
Formalin-fixed isotope-labeled reference standards and methods for fabrication and use thereof
|
GB201106254D0
(en)
|
2011-04-13 |
2011-05-25 |
Frisen Jonas |
Method and product
|
CA2849298A1
(en)
|
2011-09-22 |
2013-03-28 |
Expression Pathology, Inc. |
Mrm/srm assay for death receptor 5 protein
|
AU2012311983B2
(en)
|
2011-09-22 |
2018-02-22 |
Expression Pathology, Inc. |
Multiplex MRM assay for evaluation of cancer
|
ES2670651T3
(es)
|
2011-10-04 |
2018-05-31 |
Expression Pathology, Inc. |
Ensayo de SRM/MRM para determinar la proteína ERBB-4 del receptor de tirosina-proteína quinasa (HER4)
|
WO2013083260A1
(en)
*
|
2011-12-06 |
2013-06-13 |
Qiagen Gmbh |
Recovery of a biomolecule comprising aqueous phase from a multiphasic mixture
|
EP2805346B1
(en)
*
|
2012-01-10 |
2018-05-30 |
Expression Pathology, Inc. |
Srm/mrm assay for the insulin receptor protein
|
CN103207107B
(zh)
*
|
2012-01-16 |
2016-09-07 |
中国医学科学院北京协和医院 |
硝酸纤维素膜富集体液蛋白质组蛋白的用途
|
AU2013262727B2
(en)
|
2012-05-16 |
2017-07-27 |
Expression Pathology, Inc. |
SRM/MRM assay for subtyping lung histology
|
WO2014055832A1
(en)
*
|
2012-10-04 |
2014-04-10 |
The University Of North Carolina At Chapel Hill |
Methods and systems for using encapsulated microbubbles to process biological samples
|
CA2886974C
(en)
|
2012-10-17 |
2021-06-29 |
Spatial Transcriptomics Ab |
Methods and product for optimising localised or spatial detection of gene expression in a tissue sample
|
EP2730653A1
(en)
|
2012-11-07 |
2014-05-14 |
QIAGEN GmbH |
Method for lysing a fixed biological sample
|
JP6412100B2
(ja)
|
2013-03-15 |
2018-10-24 |
エクスプレッション、パソロジー、インコーポレイテッドExpression Pathology, Inc. |
癌療法を示すためのsrmアッセイ
|
CN111500680B
(zh)
|
2013-06-25 |
2024-04-16 |
普罗格诺西斯生物科学公司 |
检测样品中生物靶标的空间分布的方法和系统
|
CA2936077C
(en)
|
2014-01-06 |
2020-06-30 |
Expression Pathology, Inc. |
Srm assay for pd-l1
|
WO2015168483A1
(en)
*
|
2014-04-30 |
2015-11-05 |
Expression Pathology, Inc. |
Srm/mrm assay for the androgen receptor (ar) protein
|
EP3137631B1
(en)
|
2014-04-30 |
2020-01-15 |
Expression Pathology, Inc. |
Srm/mrm assay for the tyrosine-protein kinase receptor ufo (axl) protein
|
KR20200028510A
(ko)
*
|
2014-07-01 |
2020-03-16 |
익스프레션 패톨로지, 인크. |
화학요법 표적에 대한 srm 검정
|
CN106489075B
(zh)
*
|
2014-07-11 |
2019-10-15 |
爱科谱迅病理研究公司 |
针对GTP酶KRas蛋白质(KRas)的SRM/MRM测定
|
CA2987730C
(en)
|
2015-04-08 |
2020-02-18 |
Nantomics, Llc |
Cancer neoepitopes
|
CN107532207B
(zh)
|
2015-04-10 |
2021-05-07 |
空间转录公司 |
生物样本的空间区别、多重核酸分析
|
JP7236216B2
(ja)
|
2015-04-23 |
2023-03-09 |
ナントミクス,エルエルシー |
がんのネオエピトープ
|
EP3295180B1
(en)
|
2015-05-14 |
2020-07-22 |
Expression Pathology, Inc. |
Srm/mrm assay for the mesothelin (msln) protein
|
WO2016183595A1
(en)
|
2015-05-14 |
2016-11-17 |
Expression Pathology, Inc. |
Srm/mrm assay for the 6-o-methylguanine-dna methyltransferase (mgmt) protein
|
US10620223B2
(en)
|
2015-05-14 |
2020-04-14 |
Expression Pathology, Inc. |
SRM/MRM assay for the fibroblast growth factor receptor 2 (FGFR2) protein
|
CA2986730C
(en)
|
2015-05-22 |
2020-04-14 |
Expression Pathology, Inc. |
Srm/mrm assay for the cyclin-dependent kinase inhibitor 2a (p16) protein
|
AU2016270686B2
(en)
|
2015-05-29 |
2019-12-19 |
Expression Pathology, Inc. |
Quantifying Her2 protein for optimal cancer therapy
|
WO2017020048A1
(en)
|
2015-07-30 |
2017-02-02 |
Expression Pathology, Inc. |
QUANTIFYING FR-α AND GART PROTEINS FOR OPTIMAL CANCER THERAPY
|
KR20180067557A
(ko)
|
2015-09-24 |
2018-06-20 |
익스프레션 패톨로지, 인크. |
암 치료를 위한 Met 단백질의 정량화
|
US10532089B2
(en)
|
2015-10-12 |
2020-01-14 |
Nantomics, Llc |
Iterative discovery of neoepitopes and adaptive immunotherapy and methods therefor
|
WO2017066290A1
(en)
|
2015-10-12 |
2017-04-20 |
Nantomics, Llc |
Viral neoepitopes and uses thereof
|
WO2017066357A1
(en)
|
2015-10-12 |
2017-04-20 |
Nantomics, Llc |
Systems, compositions, and methods for discovery of msi and neoepitopes that predict sensitivity to checkpoint inhibitors
|
AU2016339924B2
(en)
|
2015-10-12 |
2020-01-02 |
Nantomics, Llc |
Compositions and methods for viral cancer neoepitopes
|
TWI733719B
(zh)
|
2015-12-07 |
2021-07-21 |
美商河谷控股Ip有限責任公司 |
改善的組合物及用於新表位之病毒遞送的方法及其應用
|
KR20180091119A
(ko)
|
2016-02-12 |
2018-08-14 |
난토믹스, 엘엘씨 |
암 면역요법을 위한 치료 표적으로 환자 특이적 네오에피토프의 높은 스루풋 식별 (high-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies)
|
DK3222719T3
(da)
*
|
2016-03-24 |
2020-05-11 |
Allflex Europe Sa |
Anvendelse af en vandig sammensætning til opløsning af biomolekyler fra en vævsprøve
|
US11154597B2
(en)
|
2016-03-24 |
2021-10-26 |
Nantcell, Inc. |
Sequence arrangements and sequences for neoepitope presentation
|
WO2017184905A1
(en)
*
|
2016-04-20 |
2017-10-26 |
Expression Pathology, Inc. |
Method for improved hepatocellular cancer diagnosis
|
US20190292259A1
(en)
|
2016-05-24 |
2019-09-26 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and pharmaceutical compositions for the treatment of non small cell lung cancer (nsclc) that coexists with chronic obstructive pulmonary disease (copd)
|
EP3500966B1
(en)
|
2016-08-25 |
2021-04-21 |
Nantomics, LLC |
Immunotherapy markers and uses therefor
|
US20190321481A1
(en)
|
2016-11-11 |
2019-10-24 |
Nantbio, Inc. |
Immunomodulatory compositions, processes for making the same, and methods for inhibiting cytokine storms
|
AU2017367696A1
(en)
|
2016-12-01 |
2019-06-20 |
Nant Holdings Ip, Llc |
Tumor antigenicity processing and presentation
|
WO2018102827A1
(en)
|
2016-12-04 |
2018-06-07 |
Expression Pathology, Inc. |
Improved methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy
|
WO2018122249A1
(en)
|
2016-12-28 |
2018-07-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of patients suffering from a microsatellite stable colorectal cancer
|
WO2018122245A1
(en)
|
2016-12-28 |
2018-07-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of predicting the survival time of patients suffering from cms3 colorectal cancer
|
WO2018160988A1
(en)
*
|
2017-03-03 |
2018-09-07 |
Expression Pathology, Inc. |
Immune profiling of tumor tissue
|
WO2018200389A1
(en)
|
2017-04-24 |
2018-11-01 |
Nantcell, Inc. |
Targeted neoepitope vectors and methods therefor
|
EP3619534A1
(en)
|
2017-05-05 |
2020-03-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Microtubule-targeting drugs as immune checkpoint inhibitors and methods of screening novel immune checkpoint inhibitors for the treatment of cancers and infectious diseases
|
EP3933408A1
(en)
|
2017-05-30 |
2022-01-05 |
Nant Holdings IP LLC |
Circulating tumor cell enrichment using neoepitopes
|
US10722509B2
(en)
|
2018-01-16 |
2020-07-28 |
Nantomics, Llc |
Predicting optimal chemotherapy for CRC
|
US10725045B2
(en)
|
2018-02-13 |
2020-07-28 |
Nantomics, Llc |
Quantifying MGMT protein for optimal cancer therapy of glioblastoma
|
US10722531B2
(en)
|
2018-02-13 |
2020-07-28 |
Nantomics, Llc |
OPRT expression and cancer treatment outcome
|
AU2019201463A1
(en)
|
2018-03-09 |
2019-09-26 |
Nantomics, Llc |
Srm/mrm assays for profiling tumor tissue
|
US20190353660A1
(en)
|
2018-05-17 |
2019-11-21 |
Nantomics, Llc |
Identification of cancer patients sensitive or resistant to 5-fluorouracil (5-fu)
|
US11519033B2
(en)
|
2018-08-28 |
2022-12-06 |
10X Genomics, Inc. |
Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample
|
KR20200050374A
(ko)
|
2018-10-30 |
2020-05-11 |
익스프레션 패톨로지, 인크. |
노치 경로 단백질용 srm/mrm 분석
|
CN113767177B
(zh)
|
2018-12-10 |
2025-01-14 |
10X基因组学有限公司 |
生成用于空间分析的捕获探针
|
KR20220008253A
(ko)
|
2019-01-03 |
2022-01-20 |
엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔 (인쎄름) |
암을 앓는 대상에서 cd8+ t 세포 의존성 면역 반응을 향상시키기 위한 방법 및 약학적 조성물
|
US11649485B2
(en)
|
2019-01-06 |
2023-05-16 |
10X Genomics, Inc. |
Generating capture probes for spatial analysis
|
US11926867B2
(en)
|
2019-01-06 |
2024-03-12 |
10X Genomics, Inc. |
Generating capture probes for spatial analysis
|
KR20200087700A
(ko)
|
2019-01-11 |
2020-07-21 |
난토믹스, 엘엘씨 |
질량 분석법에 의한 sdhb 단백질 발현의 평가
|
US20220177978A1
(en)
|
2019-04-02 |
2022-06-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of predicting and preventing cancer in patients having premalignant lesions
|
US20220160692A1
(en)
|
2019-04-09 |
2022-05-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of sk2 inhibitors in combination with immune checkpoint blockade therapy for the treatment of cancer
|
EP3976820A1
(en)
|
2019-05-30 |
2022-04-06 |
10X Genomics, Inc. |
Methods of detecting spatial heterogeneity of a biological sample
|
WO2020245155A1
(en)
|
2019-06-03 |
2020-12-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for modulating a treatment regimen
|
JP7215467B2
(ja)
*
|
2019-08-19 |
2023-01-31 |
株式会社島津製作所 |
ホルマリン固定パラフィン包埋組織試料からの抗体の分離、検出及び/又は分析方法
|
EP4045686A1
(en)
|
2019-10-17 |
2022-08-24 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods for diagnosing nasal intestinal type adenocarcinomas
|
EP4045912A1
(en)
|
2019-10-18 |
2022-08-24 |
Reccan Diagnostics AB |
Apparatuses and methods for detection of pancreatic cancer
|
WO2021092433A2
(en)
|
2019-11-08 |
2021-05-14 |
10X Genomics, Inc. |
Enhancing specificity of analyte binding
|
WO2021133845A1
(en)
|
2019-12-23 |
2021-07-01 |
10X Genomics, Inc. |
Reversible fixing reagents and methods of use thereof
|
CN115038794A
(zh)
|
2019-12-23 |
2022-09-09 |
10X基因组学有限公司 |
在基于分区的测定中使用固定生物样品的组合物和方法
|
SG11202106899SA
(en)
|
2019-12-23 |
2021-09-29 |
10X Genomics Inc |
Methods for spatial analysis using rna-templated ligation
|
US11702693B2
(en)
|
2020-01-21 |
2023-07-18 |
10X Genomics, Inc. |
Methods for printing cells and generating arrays of barcoded cells
|
US11732299B2
(en)
|
2020-01-21 |
2023-08-22 |
10X Genomics, Inc. |
Spatial assays with perturbed cells
|
US12076701B2
(en)
|
2020-01-31 |
2024-09-03 |
10X Genomics, Inc. |
Capturing oligonucleotides in spatial transcriptomics
|
US12110541B2
(en)
|
2020-02-03 |
2024-10-08 |
10X Genomics, Inc. |
Methods for preparing high-resolution spatial arrays
|
US11898205B2
(en)
|
2020-02-03 |
2024-02-13 |
10X Genomics, Inc. |
Increasing capture efficiency of spatial assays
|
US11732300B2
(en)
|
2020-02-05 |
2023-08-22 |
10X Genomics, Inc. |
Increasing efficiency of spatial analysis in a biological sample
|
US12129516B2
(en)
|
2020-02-07 |
2024-10-29 |
10X Genomics, Inc. |
Quantitative and automated permeabilization performance evaluation for spatial transcriptomics
|
US12281357B1
(en)
|
2020-02-14 |
2025-04-22 |
10X Genomics, Inc. |
In situ spatial barcoding
|
US11891654B2
(en)
|
2020-02-24 |
2024-02-06 |
10X Genomics, Inc. |
Methods of making gene expression libraries
|
US11926863B1
(en)
|
2020-02-27 |
2024-03-12 |
10X Genomics, Inc. |
Solid state single cell method for analyzing fixed biological cells
|
EP4110955A1
(en)
|
2020-02-28 |
2023-01-04 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing, prognosing and managing treatment of breast cancer
|
EP4127164A1
(en)
*
|
2020-03-31 |
2023-02-08 |
QIAGEN GmbH |
Nucleic acid purification from fixed biological samples
|
WO2021207610A1
(en)
|
2020-04-10 |
2021-10-14 |
10X Genomics, Inc. |
Cold protease treatment method for preparing biological samples
|
EP4136227A1
(en)
|
2020-04-16 |
2023-02-22 |
10X Genomics, Inc. |
Compositions and methods for use with fixed samples
|
ES2965354T3
(es)
|
2020-04-22 |
2024-04-12 |
10X Genomics Inc |
Métodos para análisis espacial que usan eliminación de ARN elegido como diana
|
EP4153775B1
(en)
|
2020-05-22 |
2024-07-24 |
10X Genomics, Inc. |
Simultaneous spatio-temporal measurement of gene expression and cellular activity
|
EP4153776B1
(en)
|
2020-05-22 |
2025-03-05 |
10X Genomics, Inc. |
Spatial analysis to detect sequence variants
|
US12031177B1
(en)
|
2020-06-04 |
2024-07-09 |
10X Genomics, Inc. |
Methods of enhancing spatial resolution of transcripts
|
ES2981265T3
(es)
|
2020-06-08 |
2024-10-08 |
10X Genomics Inc |
Métodos para determinar un margen quirúrgico y métodos de uso del mismo
|
EP4172362B1
(en)
|
2020-06-25 |
2024-09-18 |
10X Genomics, Inc. |
Spatial analysis of dna methylation
|
US20230266322A1
(en)
|
2020-06-30 |
2023-08-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapy and radical surgery
|
US20230235408A1
(en)
|
2020-06-30 |
2023-07-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapies
|
US11981960B1
(en)
|
2020-07-06 |
2024-05-14 |
10X Genomics, Inc. |
Spatial analysis utilizing degradable hydrogels
|
US12209280B1
(en)
|
2020-07-06 |
2025-01-28 |
10X Genomics, Inc. |
Methods of identifying abundance and location of an analyte in a biological sample using second strand synthesis
|
US11761038B1
(en)
|
2020-07-06 |
2023-09-19 |
10X Genomics, Inc. |
Methods for identifying a location of an RNA in a biological sample
|
EP4189110A1
(en)
|
2020-07-31 |
2023-06-07 |
10X Genomics, Inc. |
De-crosslinking compounds and methods of use for spatial analysis
|
US11981958B1
(en)
|
2020-08-20 |
2024-05-14 |
10X Genomics, Inc. |
Methods for spatial analysis using DNA capture
|
US11926822B1
(en)
|
2020-09-23 |
2024-03-12 |
10X Genomics, Inc. |
Three-dimensional spatial analysis
|
WO2022103712A1
(en)
|
2020-11-13 |
2022-05-19 |
10X Genomics, Inc. |
Nano-partitions (encapsulated nucleic acid processing enzymes) for cell-lysis and multiple reactions in partition-based assays
|
US11827935B1
(en)
|
2020-11-19 |
2023-11-28 |
10X Genomics, Inc. |
Methods for spatial analysis using rolling circle amplification and detection probes
|
EP4121555A1
(en)
|
2020-12-21 |
2023-01-25 |
10X Genomics, Inc. |
Methods, compositions, and systems for capturing probes and/or barcodes
|
WO2022200303A1
(en)
|
2021-03-23 |
2022-09-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the diagnosis and treatment of t cell-lymphomas
|
EP4305196B1
(en)
|
2021-04-14 |
2025-04-02 |
10X Genomics, Inc. |
Methods of measuring mislocalization of an analyte
|
EP4347879B1
(en)
|
2021-06-03 |
2025-02-19 |
10X Genomics, Inc. |
Methods, compositions, kits, and systems for enhancing analyte capture for spatial analysis
|
EP4196605B1
(en)
|
2021-09-01 |
2024-12-04 |
10X Genomics, Inc. |
Methods for blocking a capture probe on a spatial array
|
EP4419707A1
(en)
|
2021-11-10 |
2024-08-28 |
10X Genomics, Inc. |
Methods, compositions, and kits for determining the location of an analyte in a biological sample
|
WO2023102118A2
(en)
|
2021-12-01 |
2023-06-08 |
10X Genomics, Inc. |
Methods, compositions, and systems for improved in situ detection of analytes and spatial analysis
|
WO2023121449A1
(en)
|
2021-12-21 |
2023-06-29 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Central nervous system organoids
|
EP4472740A1
(en)
|
2022-01-31 |
2024-12-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Cd38 as a biomarker and biotarget in t-cell lymphomas
|
US20250035635A1
(en)
|
2022-03-17 |
2025-01-30 |
Institut National De La Sante Et De La Recherche Medicale |
Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer
|
EP4508432A1
(en)
|
2022-04-11 |
2025-02-19 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the diagnosis and treatment of t-cell malignancies
|
WO2023198874A1
(en)
|
2022-04-15 |
2023-10-19 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the diagnosis and treatment of t cell-lymphomas
|
EP4540607A1
(en)
|
2022-06-17 |
2025-04-23 |
10X Genomics, Inc. |
Catalytic de-crosslinking of samples for in situ analysis
|
WO2024003310A1
(en)
|
2022-06-30 |
2024-01-04 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the diagnosis and treatment of acute lymphoblastic leukemia
|
WO2024018046A1
(en)
|
2022-07-22 |
2024-01-25 |
Institut National de la Santé et de la Recherche Médicale |
Garp as a biomarker and biotarget in t-cell malignancies
|
WO2024023283A1
(en)
|
2022-07-29 |
2024-02-01 |
Institut National de la Santé et de la Recherche Médicale |
Lrrc33 as a biomarker and biotarget in cutaneous t-cell lymphomas
|
WO2024079192A1
(en)
|
2022-10-12 |
2024-04-18 |
Institut National de la Santé et de la Recherche Médicale |
Cd81 as a biomarker and biotarget in t-cell malignancies
|